All data are based on the daily closing price as of May 22, 2025
s

Savior Lifetec Corp.

4167.TWO
0.60 USD
-0.03
-4.76%

Overview

Last close
0.60 usd
Market cap
199.86M usd
52 week high
0.80 usd
52 week low
0.54 usd
Target price
N/A usd

Valuation

P/E
37.0536
Forward P/E
N/A
Price/Sales
5.2338
Price/Book Value
1.9119
Enterprise Value
160.99M usd
EV/Revenue
4.195
EV/EBITDA
16.2597

Key financials

Revenue TTM
38.38M usd
Gross Profit TTM
12.11M usd
EBITDA TTM
9.33M usd
Earnings per Share
0.02 usd
Dividend
N/A usd
Total assets
120.04M usd
Net debt
N/A usd

About

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Miaoli County, Taiwan.
  • Symbol
    4167.TWO
  • Exchange
    TWO
  • Isin
    TW0004167002
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Miaoli
  • Web site
    https://www.saviorlifetec.com.tw/en/
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top